Europe Interventional Cardiology Market Analysis - COVID19 - 2020-2026 - MedSuite
Throughout this medical market research, the publisher analyzed 46 interventional cardiology companies across Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of EU Interventional Cardiology Device Market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an interventional cardiology procedure volume analysis which can also be purchased as a separate report, MedPro.
Procedure Volumes for the Interventional Cardiology Market in Europe - MedPro
Coronary Stent Market - MedCore
Coronary Balloon Catheter Market - MedCore
Interventional Coronary Catheter Market - MedCore
Interventional Coronary Guidewire Market - MedCore
Coronary Embolic Protection Device Market - MedCore
Coronary Atherectomy Device Market - MedCore
Introducer Sheath Market - MedCore
Coronary Vascular Closure Device (VCD) Market - MedCore
Diagnostic Coronary Catheter & Guidewire Market - MedCore
Coronary Intravascular Ultrasound (IVUS) Market - MedCore
Coronary Optical Coherency Tomography Market - MedCore
EU Interventional Cardiology Device Market Insights
Due to COVID19, the European Interventional Cardiology market size declined by almost 27% from 2019, resulting in a valuation of approximately €928 million in 2020. The market size is expected to return to pre-COVID19 levels in 2022, and reach €1 billion in 2026.
Technologies such as computer tomography (CT), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) are becoming more efficient at diagnosing cardiovascular diseases. These higher-resolution technologies are expected to be better at identifying cardiovascular disease during the first procedure, negating the need for a second procedure and limiting the total number of diagnostic procedures performed. Prices for these image-guided devices are much higher than traditional interventional devices, resulting in upwards pressure on market value.
Boston Scientific was the leading competitor in the European market for interventional cardiology devices in 2020. The company was the leader of several segments, including coronary stents, balloon catheters, embolic protection devices, and atherectomy devices.
Report Regional Coverage:
Report Regional Coverage:
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are:
Benelux (Belgium, Netherlands, and Luxembourg)
Scandinavia (Denmark, Finland, Norway, and Sweden)